4.5 Article

Influenza virus vaccines: lessons from the 2009 H1N1 pandemic

Journal

CURRENT OPINION IN VIROLOGY
Volume 1, Issue 4, Pages 254-262

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.coviro.2011.08.002

Keywords

-

Categories

Funding

  1. Intramural NIH HHS [Z99 AI999999] Funding Source: Medline
  2. NIAID NIH HHS [Y99 AI999999] Funding Source: Medline

Ask authors/readers for more resources

Reflecting on the 2009 H1N1 pandemic, we summarize lessons regarding influenza vaccines that can be applied in the future. The two major challenges to vaccination during the 2009 H1N1 pandemic were timing and availability of vaccine. Vaccines were, however, well-tolerated and immunogenic, with inactivated vaccines containing 15 mu g of HA generally inducing antibody titers >= 1:40 in adults within 2 weeks of the administration of a single dose. Moreover, the use of oil-in-water adjuvants in Europe permitted dose-reduction, with vaccines containing as little as 3.75 or 7.5 mu g HA being immunogenic. Case-control studies demonstrated that monovalent 2009 H1N1 vaccines were effective in preventing infection with the 2009 H1N1 virus, but preliminary data suggest that it is important for individuals to be re-immunized annually.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Virology

Birnaviridae Virus Factories Show Features of Liquid-Liquid Phase Separation and Are Distinct from Paracrystalline Arrays of Virions Observed by Electron Microscopy

Vishwanatha R. A. P. Reddy, Elle A. Campbell, Joanna Wells, Jennifer Simpson, Salik Nazki, Philippa C. Hawes, Andrew J. Broadbent

Summary: Birnaviridae virus factories are not membrane bound, exhibit properties consistent with liquid-liquid phase separation, and are distinct from the paracrystalline arrays observed by transmission electron microscopy.

JOURNAL OF VIROLOGY (2022)

Editorial Material Medicine, General & Internal

What influenza activity can we anticipate in 2022?

Kanta Subbarao

Summary: We have been fortunate to avoid the co-circulation of influenza and SARS-CoV-2 since 2020, but this situation is likely to change.

MEDICAL JOURNAL OF AUSTRALIA (2022)

Article Virology

Opposing Effects of Prior Infection versus Prior Vaccination on Vaccine Immunogenicity against Influenza A(H3N2) Viruses

Annette Fox, Louise Carolan, Vivian Leung, Hoang Vu Mai Phuong, Arseniy Khvorov, Maria Auladell, Yeu-Yang Tseng, Pham Quang Thai, Ian Barr, Kanta Subbarao, Le Thi Quynh Mai, H. Rogier van Doorn, Sheena G. Sullivan

Summary: Prior vaccination and infection have different effects on the immunogenicity and effectiveness of influenza vaccines. In this study, prior infection enhanced vaccine immunogenicity, while prior vaccination attenuated it. Comparing antibody responses to A(H3N2) viruses, it was found that prior infection increased antibody titers, while prior vaccination decreased them. This study highlights the importance of considering the immunological history when developing new vaccine strains.

VIRUSES-BASEL (2022)

Editorial Material Biotechnology & Applied Microbiology

A new route to vaccines using PROTACs

Brad Gilbertson, Kanta Subbarao

Summary: An influenza vaccine is created by attenuating the live virus through targeted proteolysis.

NATURE BIOTECHNOLOGY (2022)

Article Virology

Evaluating the Breadth of Neutralizing Antibody Responses Elicited by Infectious Bursal Disease Virus Genogroup A1 Strains Using a Novel Chicken B-Cell Rescue System and Neutralization Assay

Vishwanatha R. A. P. Reddy, Salik Nazki, Andrew J. Brodrick, Amin Asfor, Joanna Urbaniec, Yasmin Morris, Andrew J. Broadbent

Summary: There is a need to evaluate the ability of vaccines to neutralize diverse IBDV genogroups and to better understand the relationship between HVR sequence, structure, and antigenicity. Here, we used a chicken B-cell line to rescue a panel of chimeric IBDVs with the HVR from seven diverse IBDV field strains and to conduct neutralization assays and protein modeling. Our novel chicken B-cell rescue system and neutralization assay can be used to screen IBDV vaccine candidates, platforms, and regimens for the breadth of neutralizing antibody responses elicited, evaluate the antigenic relatedness of diverse IBDV strains, and when coupled with structural modeling, elucidate immunodominant and conserved epitopes to strategically design novel IBDV vaccines in the future.

JOURNAL OF VIROLOGY (2022)

Article Microbiology

Sequential Transmission of Influenza Viruses in Ferrets Does Not Enhance Infectivity and Does Not Predict Transmissibility in Humans

Troy C. Sutton, Elaine W. Lamirande, Devanshi R. Patel, Katherine E. E. Johnson, Rita Czako, Elodie Ghedin, Raphael T. C. Lee, Sebastian Maurer-Stroh, Kanta Subbarao

Summary: Through sequential rounds of airborne transmission experiments in ferrets, it has been confirmed that viruses infected through the respiratory route can continue to spread in ferrets, but the transmission efficiency varies depending on the virus strain. Emerging avian influenza viruses can also transmit between ferrets through sequential transmission.
Article Virology

Heparin Inhibits SARS-CoV-2 Replication in Human Nasal Epithelial Cells

Leo Yi Yang Lee, Randy Suryadinata, Conor McCafferty, Vera Ignjatovic, Damian F. J. Purcell, Phil Robinson, Craig J. Morton, Michael W. Parker, Gary P. Anderson, Paul Monagle, Kanta Subbarao, Jessica A. Neil

Summary: The research found that heparin can effectively inhibit SARS-CoV-2 infection in nasal epithelial cells by blocking virus entry and replication. Additionally, the researchers developed a PCR detection method that can be used for virus detection in clinical studies.

VIRUSES-BASEL (2022)

Article Virology

Modeling Infectious Bursal Disease Virus (IBDV) Antigenic Drift In Vitro

Amin S. Asfor, Vishwanatha R. A. P. Reddy, Salik Nazki, Joanna Urbaniec, Andrew J. Brodrick, Andrew J. Broadbent

Summary: Infectious bursal disease virus (IBDV) vaccines do not provide sterilizing immunity and can lead to infection in vaccinated birds. Vaccine-induced immune selection pressure drives the evolution of antigenic drift variants that accumulate amino acid changes in the VP2 capsid's hypervariable region (HVR), potentially causing vaccine failures. However, little is known about the rate of mutation emergence and the contribution of different residues to immune escape.

VIRUSES-BASEL (2023)

Review Biochemistry & Molecular Biology

The Formation and Function of Birnaviridae Virus Factories

Andrew J. Brodrick, Andrew J. Broadbent

Summary: The use of IBDV reverse genetics revealed that VF are biomolecular condensates consistent with LLPS. VP3 likely initiates VF formation, which contains VP1 and dsRNA genome and serves as the site for viral RNA synthesis. The VF recruit cellular proteins, creating an optimal environment for viral replication and grow by synthesis of viral components, protein recruitment, and coalescence of multiple VFs. This review summarizes the current knowledge of VF formation, properties, composition, and processes.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Editorial Material Immunology

Mammalian infections with highly pathogenic avian influenza viruses renew concerns of pandemic potential

Brad Gilbertson, Kanta Subbarao

Summary: There is a widespread and unprecedented spread of highly pathogenic avian influenza A H5N1 viruses in bird species on five continents, with infections also reported in mammals, most likely caused by consuming infected birds. The increase in H5N1 virus infections in different species could lead to the emergence of new viral variants that may adapt to mammals and potentially humans. It is crucial to monitor and assess the presence of mutations in mammalian-origin H5N1 clade 2.3.4.4b viruses that could increase their risk for human pandemics. Although there have been a limited number of human cases so far, the infection of mammals provides opportunities for the virus to acquire mutations that enhance infection, replication, and spread in mammals, which were not observed in the past viruses.

JOURNAL OF EXPERIMENTAL MEDICINE (2023)

Article Biochemistry & Molecular Biology

Predicting the efficacy of variant-modified COVID-19 vaccine boosters

David S. Khoury, Steffen S. Docken, Kanta Subbarao, Stephen J. Kent, Miles P. Davenport, Deborah Cromer

Summary: Booster vaccination is necessary to combat waning immunity and variants of SARS-CoV-2. Data on neutralization titers from multiple sources suggest that using ancestral vaccines can enhance protection against symptomatic and severe disease caused by variant viruses. Variant-modified vaccines may provide additional benefits. This study provides evidence-based guidance for future COVID-19 vaccine regimens.

NATURE MEDICINE (2023)

Article Virology

Role of the viral polymerase during adaptation of influenza A viruses to new hosts

Brad Gilbertson, Melanie Duncan, Kanta Subbarao

Summary: This review discusses the crucial role of viral polymerase in host adaptation of influenza A viruses (IAV), focusing on the interactions between viral polymerase genes and host factors. The known viral mutations and the adaptation of avian IAV to mammalian hosts are also highlighted.

CURRENT OPINION IN VIROLOGY (2023)

Article Immunology

D4+TGFβ+ cells infiltrated the bursa of Fabricius following IBDV infection, and correlated with a delayed viral clearance, but did not correlate with disease severity, or immunosuppression

Salik Nazki, Vishwanatha R. A. P. Reddy, Nitin Kamble, Jean-Remy Sadeyen, Munir Iqbal, Shahriar Behboudi, Holly Shelton, Andrew J. Broadbent

Summary: This study suggests that CD4(+)TGF beta(+) cells infiltrate the bursa of Fabricius (BF) following IBDV infection and are associated with delayed virus clearance. However, the increase of CD4(+)TGF beta(+) cells and CD4(+)CD25(+)TGF beta(+) cells is not correlated with increased pathogenicity or immunosuppression.

FRONTIERS IN IMMUNOLOGY (2023)

Article Microbiology

Comparative Longitudinal Serological Study of Anti-SARS-CoV-2 Antibody Profiles in People with COVID-19

Marilou H. Barrios, Suellen Nicholson, Rowena A. Bull, Marianne Martinello, William Rawlinson, Michael Mina, Jeffrey J. Post, Bernard Hudson, Nicole Gilroy, Andrew R. Lloyd, Pamela Konecny, Francesca Mordant, Mike Catton, Kanta Subbarao, Leon Caly, Julian Druce, Hans J. Netter

Summary: Serological diagnostic assays are crucial for understanding an individual's immunity to SARS-CoV-2, tracking the virus spread, and evaluating population immunity. Through a dot blot assay, researchers compared the antibody profiles of individuals with different severities of COVID-19 and found patient-specific differences in the anti-SARS-CoV-2 antibody responses. These findings highlight the variability in the antibody response and the importance of considering individual differences when assessing protective antibody status.

MICROORGANISMS (2023)

Article Immunology

Off-target effects of bacillus Calmette-Guerin vaccination on immune responses to SARS-CoV-2: implications for protection against severe COVID-19

Nicole L. Messina, Susie Germano, Rebecca McElroy, Rajeev Rudraraju, Rhian Bonnici, Laure F. Pittet, Melanie R. Neeland, Suellen Nicholson, Kanta Subbarao, Nigel Curtis

Summary: BCG vaccination has immunomodulatory effects on SARS-CoV-2 and reduces the secretion of cytokines associated with severe COVID-19. In addition, BCG vaccination promotes specific T cell immune responses and activates eosinophils.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2022)

No Data Available